https://www.selleckchem.com/products/eht-1864.html
No difference in mortality was observed between the two groups. CONCLUSION This study confirms the efficacy of letermovir in preventing CMV reactivation in CMV R+ allogeneic HCT recipients in first 100 days post-HCT and suggests sustained efficacy after discontinuation of prophylaxis. © 2020 John Wiley Sons A/S. Published by John Wiley Sons Ltd.Intervertebral discs are important for maintaining mobility and offer support to the body trunk. If these discs lose their biomechanical features, lower back pain can occur. We previ